Please Hit

Folks, This is a Free Site and will ALWAYS stay that way. But the only way I offset my expenses is through the donations of my readers. PLEASE Consider Making a Donation to Keep This Site Going. SO HIT THE TIP JAR (it's on the left-hand column).

Tuesday, September 15, 2015

The10th video by The Center for Medical Progress features several top-level Planned Parenthood executives discussing the organization’s secretive practices around selling baby body parts. The video includes comments from Deborah VanDerhei, the National Director of the organization’s Consortium of Abortion Providers, describing the harvesting of body parts of aborted babies as “donation for remuneration.”

The video highlights conversations with Dr. Carolyn Westhoff, Senior Medical Advisor for PPFA; Dr. Vanessa Cullins, Vice President for External Medical Affairs for PPFA; and Deborah VanDerhei, National Director for the Consortium of Abortion Providers (CAPS) at PPFA.

“We’ve just been working with people who want particular tissues, like, you know, they want cardiac, or they want eyes, or they want neural,” says Dr. Westhoff to a prospective fetal organ buyer. “Certainly, everything we provide–oh, gonads! Oh my God, gonads. Everything we provide is fresh.” Westhoff continues, “Obviously, we would have the potential for a huge P.R. issue in doing this,” before offering to introduce the buyers to “national office abortion people” from Planned Parenthood.

Deborah VanDerhei is the National Director for CAPS, an influential committee within Planned Parenthood that drives abortion policy across the organization. VanDerhei refers to payments for fetal tissue as “donation for remuneration,” which carries the connotation of financial reward or benefit without regard for actual expenses. VanDerhei explains, “I have been talking to the executive director of the National Abortion Federation, we’re trying to figure this out as an industry, about how we’re going to manage remuneration, because the headlines would be a disaster.”

“Is this really worth getting–I don’t even know what in general, what a specimen generally brings in?” VanDerhei later asks a prospective buyer. When she is told $100 per specimen, she remarks, “But we have independent colleagues who generate a fair amount of income doing this.” VanDerhei suggests that Planned Parenthood goes to great lengths to avoid leaving a paper trail about their fetal tissue activity: “It’s an issue that you might imagine we’re not really that comfortable talking about on email.”

In a conversation recorded between VanDerhei and Vanessa Russo, Compliance Program Administrator for Planned Parenthood Keystone in Pennsylvania, Russo argues, “A company like this that wants to give our organization money for the tissue–I think that that’s a valid exchange, and that that’s okay.” VanDerhei nods her head up and down and affirms, “Mhm.”

Vanessa Cullins, the Vice President of External Medical Affairs, seems fully aware of the criminal exposure that fetal body parts sales present to Planned Parenthood: “This is important. This could destroy your organization and us, if we don’t time those conversations correctly,” she tells a prospective buyer.